19185954

Source:http://linkedlifedata.com/resource/pubmed/id/19185954

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008976, umls-concept:C0023981, umls-concept:C0087111, umls-concept:C0162836, umls-concept:C0717758
pubmed:issue	4
pubmed:dateCreated	2009-3-18
pubmed:abstractText	Medical therapies for hidradenitis suppurativa (HS) are often ineffective. Tumor necrosis factor-alpha inhibitors may be a potential treatment for patients with moderate to severe HS.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/K23 AR051125-05, http://linkedlifedata.com/resource/pubmed/grant/K23AR051125
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/19185954-11705350, http://linkedlifedata.com/resource/pubmed/commentcorrection/19185954-14632813, http://linkedlifedata.com/resource/pubmed/commentcorrection/19185954-14676068, http://linkedlifedata.com/resource/pubmed/commentcorrection/19185954-15264991, http://linkedlifedata.com/resource/pubmed/commentcorrection/19185954-15897171, http://linkedlifedata.com/resource/pubmed/commentcorrection/19185954-15916184, http://linkedlifedata.com/resource/pubmed/commentcorrection/19185954-16185263, http://linkedlifedata.com/resource/pubmed/commentcorrection/19185954-16536817, http://linkedlifedata.com/resource/pubmed/commentcorrection/19185954-16781316, http://linkedlifedata.com/resource/pubmed/commentcorrection/19185954-16982997, http://linkedlifedata.com/resource/pubmed/commentcorrection/19185954-17097366, http://linkedlifedata.com/resource/pubmed/commentcorrection/19185954-17240478, http://linkedlifedata.com/resource/pubmed/commentcorrection/19185954-17342798, http://linkedlifedata.com/resource/pubmed/commentcorrection/19185954-17373153, http://linkedlifedata.com/resource/pubmed/commentcorrection/19185954-17587838, http://linkedlifedata.com/resource/pubmed/commentcorrection/19185954-18047504, http://linkedlifedata.com/resource/pubmed/commentcorrection/19185954-18076705, http://linkedlifedata.com/resource/pubmed/commentcorrection/19185954-18083274, http://linkedlifedata.com/resource/pubmed/commentcorrection/19185954-18159906, http://linkedlifedata.com/resource/pubmed/commentcorrection/19185954-18480930, http://linkedlifedata.com/resource/pubmed/commentcorrection/19185954-18674845, http://linkedlifedata.com/resource/pubmed/commentcorrection/19185954-2702835, http://linkedlifedata.com/resource/pubmed/commentcorrection/19185954-6022733, http://linkedlifedata.com/resource/pubmed/commentcorrection/19185954-8708018, http://linkedlifedata.com/resource/pubmed/commentcorrection/19185954-9167336
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7907132
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin G, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Tumor Necrosis Factor, http://linkedlifedata.com/resource/pubmed/chemical/TNFR-Fc fusion protein, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha
pubmed:status	MEDLINE
pubmed:month	Apr
pubmed:issn	1097-6787
pubmed:author	pubmed-author:ChachkinSamuelS, pubmed-author:DommaschEricaE, pubmed-author:GelfandJoel MJM, pubmed-author:LeeRobert ARA, pubmed-author:LeydenJames JJJ, pubmed-author:Sciacca-KirbyJoslynJ, pubmed-author:ShinDaniel BDB, pubmed-author:TreatJamesJ, pubmed-author:VittorioCarmelaC, pubmed-author:WilliamsJenniferJ
pubmed:issnType	Electronic
pubmed:volume	60
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	565-73
pubmed:dateRevised	2011-9-26
pubmed:meshHeading	pubmed-meshheading:19185954-Adult, pubmed-meshheading:19185954-Female, pubmed-meshheading:19185954-Hidradenitis Suppurativa, pubmed-meshheading:19185954-Humans, pubmed-meshheading:19185954-Immunoglobulin G, pubmed-meshheading:19185954-Male, pubmed-meshheading:19185954-Middle Aged, pubmed-meshheading:19185954-Prospective Studies, pubmed-meshheading:19185954-Receptors, Tumor Necrosis Factor, pubmed-meshheading:19185954-Tumor Necrosis Factor-alpha
pubmed:year	2009
pubmed:articleTitle	A prospective clinical trial of open-label etanercept for the treatment of hidradenitis suppurativa.
pubmed:affiliation	Department of Dermatology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA.
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't, Clinical Trial, Phase II, Research Support, N.I.H., Extramural